The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Uterine Diseases

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Uterine Diseases


High impact information on Uterine Diseases

  • Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment [3].
  • Normal tissue from patients with SCC showed significantly higher triglycerides than normal tissue from patients with benign uterine disease but significantly lower triglycerides than SCC tissue [4].
  • DESIGN AND PATIENTS: Thirty-seven fertile women undergoing surgery for benign uterine diseases were divided into 3 groups and monitored for 12 months: hysterectomized women (n = 9), ovariectomized untreated women (n = 12) and ovariectomized women starting treatment with transdermal estradiol (E2, 50 microg/d) 1 month after surgery (n = 16) [5].

Gene context of Uterine Diseases

  • Pretreatment serum levels of soluble interleukin-2 receptor (sIL-2R), CA 125, and SCC were measured in 183 patients with malignant or benign uterine diseases [6].


  1. Serum interleukin-6 levels in uterine malignancies. Preliminary data. Ferdeghini, M., Gadducci, A., Prontera, C., Bonuccelli, A., Annicchiarico, C., Fanucchi, A., Facchini, V., Bianchi, R. Anticancer Res. (1994) [Pubmed]
  2. Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix. Ferdeghini, M., Gadducci, A., Annicchiarico, C., Prontera, C., Malagnino, G., Castellani, C., Facchini, V., Bianchi, R. Anticancer Res. (1993) [Pubmed]
  3. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Bulun, S.E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., Tamura, M., Langoi, D., Deb, S. Pharmacol. Rev. (2005) [Pubmed]
  4. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study. Mahon, M.M., deSouza, N.M., Dina, R., Soutter, W.P., McIndoe, G.A., Williams, A.D., Cox, I.J. NMR in biomedicine. (2004) [Pubmed]
  5. Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Girasole, G., Giuliani, N., Modena, A.B., Passeri, G., Pedrazzoni, M. Clin. Endocrinol. (Oxf) (1999) [Pubmed]
  6. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data. Ferdeghini, M., Gadducci, A., Prontera, C., Marrai, R., Malagnino, G., Annicchiarico, C., Fioretti, P., Bianchi, R. Anticancer Res. (1993) [Pubmed]
WikiGenes - Universities